Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Capricor Therapeutics Inc’s current trading price is -45.04% away from its 52-week high, while its distance from the 52-week low is 265.34%. The stock’s price range during this period has varied between $3.52 and $23.40. The company, active in the Healthcare sector, saw a trading volume of around 2.65 million for the day, considerably higher average daily volume of 1.1 million observed over the last three months.
The market performance of Capricor Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $23.40 on 10/15/24, with the lowest value for the same timeframe being $3.52, recorded on 08/07/24.
How Financial Performance Impacts Market Capitalization
Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -2.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 584.74M and boasts a workforce of 102 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.39, with a change in price of -8.35. Similarly, Capricor Therapeutics Inc recorded 1,263,658 in trading volume during the last 100 days, posting a change of -39.37%.
How CAPR’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
CAPR Stock Stochastic Average
As of today, the raw stochastic average of Capricor Therapeutics Inc over the last 50 days is at 26.65%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 27.70%. Further, the company’s Stochastic %K and %D values for the last 20 days were 33.76% and 23.95%, respectively.
CAPR Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -6.81%.However, over the last six months, we can see a weaker performance of 151.17%. Over the last 30 days, the price of CAPR has leaped by -15.12%. And in the last five days, it has fallen by -2.80%.
